Archive for the ‘Main’ Category

Gastrointestinal side effects associated with NSAID and aspirin use range in severity from minor, superficial mucosal injury to ul-ceration, perforation, gastric outlet obstruction, and hemorrhage. These effects represent a substantial source of drug-induced morbidity and mortality among Americans. Hospitalizations resulting from gastrointestinal disorders are at least six times more frequent in patients with arthritis who [...]

The physiological reaction to injury, noxious agents, and autoimmune-triggered substances consists of an innate, non-immunologic response and an acquired, specific immune re-sponse. During this highly complex repertoire of responses, referred to as the inflammatory reaction (Figure 1), numerous mediators of inflammation (e.g., eicosanoids, histamine, platelet-activating factor [PAF], bradykinin, and cytokines) are synthesized or released. Of [...]

Introduction
Between 10% and 15% of older Americans use a prescription nonsteroidal anti-inflammatory drug (NSAID) at least once daily. In addition, it is estimated that the use of over-the-counter nonprescription NSAIDs, which include aspirin, may be five to seven times greater than for prescribed NSAIDs. Numerous studies have confirmed that NSAIDs are clinically effective analgesic agents [...]

Table 5 lists all treatment-related clinical adverse events that occurred in 3% or more of the Hepsera™-treated patients compared with those receiving placebo. Increased asthenia, headache, and abdominal pain are the most frequently reported adverse events, followed by nausea and flatulence. Two other less commonly reported side effects are diarrhea and dyspepsia.

From a 10-mg single dose of Hep-sera™, the approximate bioavailability of adefovir is 59%. After oral administration of a 10-mg single dose of Hepsera™ to patients with chronic hepatitis B, the peak adefovir plasma concentration has been 18.4 + 6.26 ng/ml, occurring between 0.58 and 4.00 hours after a dose. The adefovir area under the [...]

Adefovir Dipivoxil

In: Main

23 Jun 2010

INTRODUCTION
The leading cause of cirrhosis and hepatocellular carcinoma around the world is chronic hepatitis B virus (HBV) infection. Approximately 10% of patients who carry the human immunodeficiency virus (HIV) in the U.S. are co-infected with HBV and face decreased survival rates. Worldwide, 400 million people are chronically infected with hepatitis B.

Don’t assume for a second that Republican control of the House, Senate, and White House ensures passage of the Bush Medicare drug benefit, or any other benefit for that matter, in 2003. Although Republican leaders on Capitol Hill gave President Bush’s hazy, early March drug proposal polite applause, you didn’t need special, Pentagon-issue night-vision goggles [...]

Pages: Prev 1 2 3 4 5 6 7 8 9 10 11 Next

About this blog

Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.

Photostream

    Medirigiriya_Ruins_001
    Dropper, London, UK
    Who's Sick?
    37/366 - Sick Day
    Project 365: Day 37
    intestines
    37/366.
    stomach
    190/365 Poison Bottle Stars - HMM :)
  • Shelby Miller: Hi, i'm doing a project called History day. The theme is innovation in history and I choose Anesthes [...]
  • Tim Tav: For newly qualified dentists it may help to join firms with a training department that may help to s [...]
  • Prierien: Great. Now I can say thank you! [...]
  • Mark: I bookmarked this link. Thank you for good job! [...]
  • Robor: Hi, Thank you! I would now go on this blog every day! Robor [...]

Tags